|
US3135743A
(en)
|
1960-06-29 |
1964-06-02 |
Sterling Drug Inc |
Steroido[2. 3-d]isoxazoles and preparation thereof
|
|
NL241544A
(fr)
|
1958-07-23 |
|
|
|
|
GB1123770A
(en)
|
1966-11-15 |
1968-08-14 |
Sterling Drug Inc |
2-cyano-3-oxo-steroids
|
|
US4160027A
(en)
|
1977-12-20 |
1979-07-03 |
Sterling Drug Inc. |
Steroid cyanoketones and intermediates
|
|
US4994443A
(en)
|
1982-12-20 |
1991-02-19 |
The Children's Medical Center Corporation |
Inhibition of angiogenesis
|
|
US5714481A
(en)
|
1983-08-02 |
1998-02-03 |
Research Corporation Technologies, Inc. |
Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
|
|
US4617299A
(en)
|
1983-12-19 |
1986-10-14 |
Knepper Paul A |
Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
|
|
US4837212A
(en)
|
1984-11-15 |
1989-06-06 |
University Of Miami |
Treatment of hemolytic anemia with danazol
|
|
US4975537A
(en)
|
1985-10-23 |
1990-12-04 |
The Upjohn Company |
Δ9(11) -angiostatic steroids
|
|
AU604236B2
(en)
|
1986-04-28 |
1990-12-13 |
Iolab, Inc. |
Intraocular dosage compositions and method of use
|
|
DE3738620A1
(de)
|
1987-11-13 |
1989-05-24 |
Luderschmidt Christoph |
Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
|
|
US5407926A
(en)
|
1987-12-29 |
1995-04-18 |
Alcon Laboratories, Inc. |
Ophthalmic composition
|
|
JP2680614B2
(ja)
|
1988-08-01 |
1997-11-19 |
日清製粉株式会社 |
ダナゾール組成物
|
|
US5990099A
(en)
|
1988-10-31 |
1999-11-23 |
Alcon Laboratories, Inc. |
Angiostatic agents and methods and compositions for controlling ocular hypertension
|
|
US5372996A
(en)
|
1989-03-10 |
1994-12-13 |
Endorecherche, Inc. |
Method of treatment of androgen-related diseases
|
|
ATE170753T1
(de)
|
1989-07-07 |
1998-09-15 |
Endorecherche Inc |
Androgenderivate zur hemming der aktivität der sexualsteroide
|
|
US5972922A
(en)
|
1990-06-11 |
1999-10-26 |
Alcon Laboratories, Inc. |
Steroids which inhibit angiogenesis
|
|
DE69132048T2
(de)
|
1990-06-11 |
2000-07-13 |
Alcon Lab Inc N D Ges D Staate |
Verwendung von Steroiden zur Inhibierung von Angiogenesis
|
|
JPH04149132A
(ja)
|
1990-10-13 |
1992-05-22 |
Bairon Boeki Kk |
ダナゾール水溶液
|
|
JPH0735335B2
(ja)
|
1991-02-28 |
1995-04-19 |
五十嵐 正雄 |
子宮内膜症の治療薬
|
|
EP0593520B1
(fr)
|
1991-06-18 |
1999-09-29 |
Laboratoire Theramex S.A. |
Compositions oculaires contenant des steroides et leur utilisation pour le traitement du glaucome
|
|
CA2425849C
(fr)
|
1991-11-22 |
2007-02-27 |
Alcon Laboratories, Inc. |
Steroides angiostatiques
|
|
US5679666A
(en)
|
1991-11-22 |
1997-10-21 |
Alcon Laboratories, Inc. |
Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids
|
|
US5770592A
(en)
|
1991-11-22 |
1998-06-23 |
Alcon Laboratories, Inc. |
Prevention and treatment of ocular neovascularization using angiostatic steroids
|
|
GB9200210D0
(en)
|
1992-01-07 |
1992-02-26 |
British Bio Technology |
Compounds
|
|
JPH07508716A
(ja)
|
1992-04-21 |
1995-09-28 |
ザ スキーペンズ アイ リサーチ インスティテュート，インコーポレイテッド |
シェーグレン症候群における眼のアンドロゲン療法
|
|
ES2068742B1
(es)
|
1993-02-11 |
1995-11-16 |
Uriach & Cia Sa J |
Nuevos derivados de piridinio.
|
|
WO1995003807A1
(fr)
|
1993-07-27 |
1995-02-09 |
The University Of Sydney |
Traitement de la degenerescence maculaire due au vieillissement
|
|
US5646136A
(en)
|
1994-01-04 |
1997-07-08 |
Duke University |
Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
|
|
NZ283658A
(en)
|
1994-04-04 |
1999-09-29 |
William R Freeman |
Compositions and treatment of increased intraocular pressure with phosphonyl-alkyloxy-pyrimidines/purines (nucleosides)
|
|
WO2002096927A2
(fr)
|
2001-05-29 |
2002-12-05 |
Ribozyme Pharmaceuticals, Incorporated |
Modulation a base de l'acide nucleique des maladies et troubles de l'appareil reproducteur chez la femme
|
|
US5885591A
(en)
|
1996-07-02 |
1999-03-23 |
Johnson & Johnson Consumer Products, Inc. |
Personal lubricant compositions
|
|
US5929111A
(en)
|
1996-12-18 |
1999-07-27 |
Alcon Laboratories, Inc. |
A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure
|
|
US5993856A
(en)
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
|
WO1998043647A1
(fr)
|
1997-03-28 |
1998-10-08 |
Massachusetts Institute Of Technology, Inc. |
Regulation de l'expression de la proteine precurseur amyloide (app) au moyen de composes oestrogeniques
|
|
US6011023A
(en)
|
1997-08-27 |
2000-01-04 |
Alcon Laboratories, Inc. |
Angiostatic steroids
|
|
US6054446A
(en)
|
1997-12-24 |
2000-04-25 |
Sri International |
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
|
|
EP0939124A3
(fr)
|
1998-02-24 |
2001-03-21 |
Smithkline Beecham Plc |
Séquences de la MBGP1
|
|
US6645954B2
(en)
|
1998-04-09 |
2003-11-11 |
Multimed Limited |
Compositions comprising ethisterone or its derivatives
|
|
GB9807809D0
(en)
|
1998-04-09 |
1998-06-10 |
Multimed Ltd |
Compositions comprising ethisterone or its derivatives
|
|
WO2000002564A1
(fr)
|
1998-07-10 |
2000-01-20 |
The University Of Sydney |
Traitements prophylactiques de la neoformation de vaisseaux sanguins dans la degenerescence maculaire
|
|
US20040063719A1
(en)
|
1998-08-26 |
2004-04-01 |
Queen's University At Kingston |
Combination therapy using antihypertensive agents and endothelin antagonists
|
|
EP1022027A1
(fr)
|
1999-01-22 |
2000-07-26 |
Applied Research Systems ARS Holding N.V. |
Antagonistes du TNF (Tumor necrosis factor) et leurs utilisations contre l'endometriose
|
|
EP1074634B1
(fr)
|
1999-07-09 |
2002-10-02 |
Institut Pasteur De Lille |
Procédé pour le diagnostic ou le prognostic de la maladie d'Alzheimer: Composition therapeutique pour la prévention ou le traitement de la maladie d'Alzheimer
|
|
US6610674B1
(en)
|
1999-09-28 |
2003-08-26 |
University Of Pennsylvania |
Method of treating inflammatory conditions with progesterone analogs
|
|
KR100732262B1
(ko)
|
1999-10-21 |
2007-06-25 |
알콘, 인코퍼레이티드 |
약물 전달 장치
|
|
WO2001030337A2
(fr)
|
1999-10-22 |
2001-05-03 |
Orbon Corporation |
Traitement topique de l'hypertension oculaire, du glaucome, de la retinopathie ischemique et de la degenerescence maculaire liee a l'age par une formulation ophtalmique d'antagonistes de la dopamine
|
|
US6562369B2
(en)
|
1999-12-16 |
2003-05-13 |
Dermatrends, Inc. |
Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
|
|
US6632818B2
(en)
|
2000-01-12 |
2003-10-14 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
GB2345851B
(en)
|
2000-01-18 |
2004-05-26 |
Gavin Paul Vinson |
A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour
|
|
US20020055512A1
(en)
|
2000-01-21 |
2002-05-09 |
Cortendo Ab. |
Compositions for delivery of a cortisol antagonist
|
|
AU785285B2
(en)
|
2000-03-10 |
2006-12-21 |
Sun Pharma Global Fze |
Methods and compositions for treating and preventing posterior segment ophthalmic disorders
|
|
ES2381775T3
(es)
|
2000-08-04 |
2012-05-31 |
Dmi Biosciences, Inc. |
Procedimiento del uso de dicetopiperazinas y composición que las contiene
|
|
US20040082557A1
(en)
|
2001-01-26 |
2004-04-29 |
Wajszczuk Charles Paul |
Methods for treating estrogen-dependent disorders
|
|
EP2135611A1
(fr)
|
2001-03-01 |
2009-12-23 |
Hollis-Eden Pharmaceuticals Inc. |
Derivés de Pregn-5-en-20-yn-3,7,17-triol pour utilisation thérapeutique
|
|
GB2375958B
(en)
|
2001-04-09 |
2005-03-02 |
George Margetts |
The use of steroids to lower the levels of cortisol
|
|
US6936599B2
(en)
|
2001-04-25 |
2005-08-30 |
The Regents Of The University Of California |
Estriol therapy for multiple sclerosis and other autoimmune diseases
|
|
WO2002087543A1
(fr)
|
2001-05-01 |
2002-11-07 |
Biozone Laboratories, Inc. |
Preparations a liberation prolongee de nifedipine, de dextromethorphane et de danazol
|
|
FR2825277B1
(fr)
|
2001-05-30 |
2004-10-15 |
Oreal |
Composition cosmetique et/ou dermatologique et/ou pharmaceutique contenant au moins un compose ihnibiteur de l'enzime 3, b-hsd
|
|
US20030232798A1
(en)
|
2001-06-12 |
2003-12-18 |
Yadon Arad |
Adrenal enzyme inhibitors
|
|
US20030050291A1
(en)
|
2001-06-12 |
2003-03-13 |
Yadon Arad |
Adrenal enzyme inhibitors
|
|
CA2456034A1
(fr)
|
2001-08-03 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Medicaments a liberation continue
|
|
JP2006506321A
(ja)
|
2002-04-11 |
2006-02-23 |
チルドレンズ メディカル センター コーポレーション |
血管透過性亢進を阻害する方法
|
|
WO2004019953A1
(fr)
|
2002-08-28 |
2004-03-11 |
Hollis-Eden Pharmaceuticals, Inc. |
Procedes de traitement therapeutique
|
|
US7354574B2
(en)
|
2002-11-07 |
2008-04-08 |
Advanced Ocular Systems Limited |
Treatment of ocular disease
|
|
AU2003303033B2
(en)
|
2002-12-18 |
2009-06-04 |
Besins Healthcare Luxembourg Sarl |
Treatment of mastalgia with 4-hydroxy tamoxifen
|
|
WO2004058289A1
(fr)
|
2002-12-20 |
2004-07-15 |
Chakshu Research, Inc. |
Formulation ophtalmique pour la prevention et le traitement de pathologies oculaires
|
|
EP1578421A4
(fr)
|
2003-01-02 |
2009-04-22 |
Femmepharma Holding Co Inc |
Preparations pharmaceutiques permettant le traitement de maladies et d'affections du sein
|
|
CN100342856C
(zh)
|
2003-04-10 |
2007-10-17 |
上海医药工业研究院 |
达那唑半固体骨架制剂的组合物
|
|
GB2400554B
(en)
|
2003-04-16 |
2007-04-18 |
George Margetts |
Treatment of angiotensin II-induced cardiovascular disease
|
|
WO2004103406A1
(fr)
|
2003-05-26 |
2004-12-02 |
Japan Science And Technology Agency |
Composition therapeutique contre des maladies s'accompagnant d'une dimension ou d'une augmentation des plaquettes
|
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
WO2005053660A2
(fr)
|
2003-12-03 |
2005-06-16 |
Lifecycle Pharma A/S |
Compositions pharmaceutiques comprenant du danazol
|
|
GB0329667D0
(en)
|
2003-12-22 |
2004-01-28 |
King S College London |
Core 2 GlcNAc-T inhibitor
|
|
US20050143362A1
(en)
|
2003-12-31 |
2005-06-30 |
Mclane Michael W. |
Danazol for treatment of hypogonadism in the adult male
|
|
US7442681B2
(en)
|
2004-02-10 |
2008-10-28 |
University Of Virginia Patent Foundation |
Method of inhibiting vascular permeability
|
|
WO2005091853A2
(fr)
|
2004-02-27 |
2005-10-06 |
Centocor, Inc. |
Procedes et compositions pour traiter des pathologies associees a l'il-13
|
|
EP1737452A1
(fr)
|
2004-04-06 |
2007-01-03 |
Angiogenetics Sweden AB |
Composes agissant sur l'angiogenese et procedes d'utilisation de ceux-ci
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
WO2006004795A2
(fr)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Inhibiteurs d'angiogenese
|
|
GB2420281A
(en)
|
2004-11-22 |
2006-05-24 |
Stegram Pharmaceuticals Ltd |
Topical formulations for use in the treatment or prevention of dermatological conditions
|
|
GB2421183A
(en)
|
2004-12-17 |
2006-06-21 |
Stegram Pharmaceuticals Ltd |
Topical formulations for use in the treatment or prevention of skin cancers
|
|
EP1848541A4
(fr)
|
2005-02-07 |
2013-01-16 |
Pharmalight Inc |
Procede et dispositif d'administration ophtalmique d'ingredients pharmaceutiquement actifs
|
|
EP2500031A3
(fr)
|
2005-02-24 |
2012-12-26 |
Joslin Diabetes Center, Inc. |
Compositions et procédés de traitement de la perméabilité vasculaire
|
|
WO2006094027A2
(fr)
|
2005-03-02 |
2006-09-08 |
Nascent Pharmaceutical, Inc. |
Polytherapie pour une application topique dans le traitement de degenerescence maculaire liee a l'age et d'hypertension oculaire
|
|
DE202006021081U1
(de)
*
|
2005-07-12 |
2012-05-08 |
Dmi Biosciences, Inc. |
Produkte zur Behandlung von Krankheiten
|
|
US8404643B2
(en)
|
2005-12-22 |
2013-03-26 |
Takeda Pharmaceutical Company Limited |
Metastin derivatives and use thereof
|
|
US20070173538A1
(en)
|
2005-12-23 |
2007-07-26 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
US20100330148A1
(en)
|
2006-03-20 |
2010-12-30 |
The Johns Hopkins University |
Mehods and compositions for inhibiting impdh-1 isoform 1
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
CN101024082A
(zh)
|
2007-04-06 |
2007-08-29 |
张士东 |
一种全面预防和治疗心脑血管疾病复方药及其应用
|
|
ES2493641T3
(es)
|
2007-06-28 |
2014-09-12 |
Cydex Pharmaceuticals, Inc. |
Administración nasal de soluciones acuosas de corticosteroides
|
|
WO2009036108A1
(fr)
|
2007-09-13 |
2009-03-19 |
Children's Medical Center Corporation |
Procédés et compositions pour inhiber une fuite vasculaire
|
|
JP5767812B2
(ja)
|
2007-12-06 |
2015-08-19 |
バーグ リミテッド ライアビリティ カンパニー |
生物学的利用率が向上した吸入可能な組成物
|
|
US8217047B2
(en)
*
|
2008-05-27 |
2012-07-10 |
Dmi Acquisition Corp. |
Therapeutic methods and compounds
|
|
CA2765883A1
(fr)
|
2009-06-22 |
2010-12-29 |
Dmi Acquisition Corp. |
Procedes et produits de traitement de maladies
|
|
AU2010264524B2
(en)
*
|
2009-06-22 |
2015-03-19 |
Ampio Pharmaceuticals, Inc. |
Method for treatment of diseases
|
|
WO2013052869A1
(fr)
|
2011-10-07 |
2013-04-11 |
Ampio Pharmaceuticals, Inc. |
Traitement de la rhinite
|
|
AU2013361338A1
(en)
*
|
2012-12-19 |
2015-08-06 |
Ampio Pharmaceuticals, Inc. |
Method for treatment of diseases
|